Arthritis

A recent study presented at the American College of Rheumatology (ACR) 2025 Annual Meeting has revealed a promising link between GLP-1 receptor agonists—a class of drugs commonly prescribed for diabetes and weight management—and a reduction in rheumatoid arthritis (RA) flares. Researchers observed that patients using GLP-1 therapies experienced fewer inflammatory episodes, improved mobility, and better overall disease control compared to those on standard treatment alone.

In World Arthritis Day, health experts have sounded the alarm over an increasing prevalence of arthritis and autoimmune diseases among younger populations. Once considered ailments predominantly affecting the elderly, these conditions are now manifesting in adolescents and young adults, driven by factors such as sedentary lifestyles, poor diet, stress, and genetic predispositions. Early diagnosis, lifestyle modification, and proactive management are being emphasized to mitigate long-term disability and enhance quality of life.